Does 5-HTP help with mood, sleep and appetite?

Your brain produces serotonin in two steps: dietary tryptophan is first converted to 5-HTP by an enzyme called tryptophan hydroxylase, and then 5-HTP is converted to serotonin by another enzyme, aromatic amino acid decarboxylase. The first step is the bottleneck — tryptophan hydroxylase is easily saturated and competes with other amino acids for transport across the blood-brain barrier.

5-HTP sidesteps this problem entirely. It enters the brain directly and efficiently (approximately 70% oral bioavailability), where it is rapidly converted to serotonin^5,6. Because it doesn't compete with other amino acids for transport, it works whether or not you've eaten protein — unlike tryptophan supplements.

Serotonin itself doesn't cross the blood-brain barrier, so raising serotonin by taking 5-HTP (which works inside the brain) is fundamentally different from raising peripheral serotonin through food.

Mood Support

The most studied use of 5-HTP is for depression. A 2020 systematic review and meta-analysis covering 13 investigations found a depression remission rate of 65% and a large effect size (Hedges' g = 1.11)¹. A double-blind RCT directly comparing 5-HTP to fluoxetine (Prozac) in 60 patients with first-episode depression found both produced nearly identical improvements on the Hamilton Depression Rating Scale, with response rates of 73% versus 80% respectively². The authors concluded that 5-HTP had "definitely got antidepressant effect equal to that of fluoxetine."

That said, the review's risk-of-bias assessment suggested that current studies are relatively weak, with few including placebo groups — the evidence is positive but calls for more rigorous studies¹.

Typical doses studied: 50–300 mg/day, often split into two doses.

Sleep Quality

5-HTP supports sleep by increasing serotonin, which the brain's pineal gland uses to make melatonin during darkness. A 2024 randomized controlled trial in older adults (100 mg/day for 12 weeks) found that poor sleepers experienced significant improvements in the Global Sleep Score and reduced sleep latency by the end of the trial³. Serum serotonin increased, and gut microbiota diversity improved — particularly bacteria that produce short-chain fatty acids, pointing to a gut-brain axis connection.

Taking 5-HTP in the evening (20–30 minutes before bed) is the most common approach for sleep support. Combining it with B6 may enhance conversion to serotonin, though the additional benefit is not well established in trials.

Appetite and Weight

In a small double-blind randomized trial, 5-HTP reduced carbohydrate intake and produced early satiety. Obese adults taking 900 mg/day lost significant weight even without being instructed to diet⁴. Significant weight loss on 5-HTP was seen again in a second 6-week period, when a 5040-kJ/d diet was recommended⁴.

The mechanism appears to be serotonergic signaling in the hypothalamus, which modulates hunger and meal termination.

Dosing and Considerations

• Depression/mood: 100–300 mg/day, often divided doses
• Sleep: 50–100 mg taken 30–60 minutes before bed
• Appetite: 100–300 mg before meals

5-HTP should not be combined with SSRIs, SNRIs, MAOIs, or other serotonergic medications without medical supervision — the combination can theoretically cause serotonin syndrome, a serious condition involving excessive serotonin activity⁶. This is not a supplement to take casually alongside antidepressant medications.

Some people experience GI side effects (nausea, diarrhea) at higher doses; starting low and increasing gradually helps. Taking it with a small amount of food can reduce nausea.

See our magnesium page for another evidence-based approach to sleep, and our l-theanine page for anxiety support without drowsiness.

Depression

The most comprehensive evidence comes from a 2020 systematic review and meta-analysis (Javelle et al., Nutrition Reviews) covering 13 investigations, 7 of which were included in a quantitative meta-analysis¹. The pooled remission rate was 65% (95% CI: 55–78%), with a large effect size (Hedges' g = 1.11, 95% CI: 0.53–1.69). The authors noted substantial heterogeneity across studies and called for better-designed trials.

The 2013 RCT by Jangid et al. (Asian Journal of Psychiatry, n=60) is one of the cleaner head-to-head comparisons: a double-blind 8-week trial randomized first-episode depressed patients to either 5-HTP or fluoxetine 20 mg/day². HAM-D scores declined significantly and nearly identically in both groups beginning at week 2. Response rates were 73.3% (5-HTP) vs. 80% (fluoxetine) — a non-significant difference. This is notable given that 5-HTP lacks the regulatory support and multi-billion-dollar development investment behind SSRIs.

The same review is more cautious about study quality: its risk-of-bias assessment (the OHAT tool) suggested that, on the whole, current studies are relatively weak, with few including placebo groups¹. The authors concluded that further trials should be placebo-controlled and enroll patients with well-defined depression diagnoses.

Sleep

The most rigorous sleep data comes from a 2024 Singapore RCT (Sutanto et al., Clinical Nutrition, n=30, mean age 66) using 100 mg/day for 12 weeks³. In the subgroup of poor sleepers (PSQI score ≥5), the Global Sleep Score improved significantly by week 12, with reduced sleep latency. Serum serotonin levels rose significantly in the active group. Gut microbiota analysis found increased abundance of SCFA-producing genera, suggesting an effect on the gut-brain axis that may mediate some sleep benefits.

Earlier mechanistic work (Nakazawa et al., 1980) found that 200 mg oral 5-HTP altered sleep architecture in normal subjects — decreasing Stage 1 sleep; after a night of sleep deprivation it also increased Stage 2 and abolished the rebound in slow-wave sleep seen with placebo — though the significance of these architectural changes for sleep quality is unclear⁸.

Appetite and Weight Management

Cangiano et al. (American Journal of Clinical Nutrition, 1992) conducted a double-blind randomized trial in which 20 obese adults received 900 mg/day 5-HTP or placebo over two consecutive 6-week periods (without, then with, dietary advice)⁴. Significant weight loss was observed in the 5-HTP-treated patients during both periods. A reduction in carbohydrate intake and a consistent presence of early satiety were also found.

The trial was also designed to test whether 5-HTP could improve adherence to dietary restriction: no diet was prescribed in the first period, and a 5040-kJ/d diet was recommended in the second. The authors concluded that, together with the good tolerance observed, the findings suggest 5-HTP may be safely used to treat obesity⁴.

Safety

The safety profile of 5-HTP is generally favorable in short-term trials. A comprehensive 2004 review (Das et al., Toxicology Letters) found no confirmed cases of eosinophilia-myalgia syndrome (EMS) — the condition that led to tryptophan being pulled from sale in 1989 — in over 20 years of 5-HTP use worldwide⁷. Unlike the tryptophan EMS outbreak (which was traced to a specific contaminated batch from one manufacturer), 5-HTP has not been implicated in similar events. The review identified a chromatographic peak sometimes found in 5-HTP products but attributed it to an artifact at negligible concentrations.

The primary safety concern is serotonin syndrome when combined with serotonergic drugs (SSRIs, MAOIs, triptans, tramadol). GI side effects are the most common complaint in trials, dose-dependent and manageable by starting at 50 mg and increasing gradually.

Long-term use beyond 12 weeks is poorly studied. Based on the available evidence, 5-HTP appears to be a moderately effective and well-tolerated option for mood, sleep, and appetite support — with the important caveat that it should not be combined with prescription serotonergic medications.